Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
EOLS on Nasdaq
Shares outstanding
64,670,984
Price per share
$6.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
54,269,227
Total reported value
$333,225,539
% of total 13F portfolios
0%
Share change
-4,056,421
Value change
-$49,044,162
Number of holders
158
Price from insider filings
$6.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 8.8% +49% $35,162,902 +$12,129,656 5,726,857 +53% Nantahala Capital Management, LLC 30 Sep 2025
LYNCH TIMOTHY P 7.9% +27% $31,521,385 +$6,381,222 5,133,776 +25% Timothy P. Lynch 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC 7.9% $47,675,186 4,997,399 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
BlackRock, Inc. 6.9% $41,641,108 4,364,896 BlackRock, Inc. 31 Dec 2024
Caligan Partners LP 6.4% +24% $25,413,110 +$4,893,414 4,138,943 +24% Caligan Partners LP 30 Sep 2025
PERCEPTIVE ADVISORS LLC 3.8% -43% $18,759,310 -$12,539,586 2,474,843 -40% Perceptive Advisors LLC 30 Jun 2025
Medytox Inc. 3.4% $20,381,723 2,136,449 Medytox Inc. 31 Dec 2024

As of 30 Sep 2025, 158 institutional investors reported holding 54,269,227 shares of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS). This represents 84% of the company’s total 64,670,984 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 8.9% 5,726,857 +36% 2.2% $35,162,902
TANG CAPITAL MANAGEMENT LLC 8.5% 5,488,299 +9.8% 1.3% $33,698,156
BlackRock, Inc. 6.9% 4,476,691 +7% 0% $27,486,880
Caligan Partners LP 6.4% 4,138,943 +24% 3.5% $25,413,110
VANGUARD GROUP INC 5.3% 3,428,943 +3.3% 0% $21,053,710
Frazier Life Sciences Management, L.P. 4.1% 2,630,665 +8% 0.48% $16,152,283
MILLENNIUM MANAGEMENT LLC 2.9% 1,859,003 +25% 0.01% $11,414,278
Stonepine Capital Management, LLC 2.4% 1,536,391 +68% 7.7% $9,433,441
STATE STREET CORP 2.3% 1,515,217 +7.7% 0% $9,303,432
Eversept Partners, LP 2.3% 1,475,109 +26% 0.69% $9,057,169
Soleus Capital Management, L.P. 2.2% 1,450,000 -32% 0.48% $8,903,000
GEODE CAPITAL MANAGEMENT, LLC 2.2% 1,417,192 +15% 0% $8,702,787
D. E. Shaw & Co., Inc. 2.1% 1,354,395 +41% 0.01% $8,315,986
RICE HALL JAMES & ASSOCIATES, LLC 1.8% 1,168,886 +17% 0.39% $7,176,960
Nuveen, LLC 1.7% 1,071,367 +20% 0% $6,578,193
UBS Group AG 1.6% 1,030,116 -4.3% 0% $6,324,913
BOOTHBAY FUND MANAGEMENT, LLC 1.6% 1,029,701 -12% 0.16% $6,322,364
SCHRODER INVESTMENT MANAGEMENT GROUP 1.6% 1,014,473 -4% 0% $6,228,864
PINNACLE ASSOCIATES LTD 1% 674,875 -1.6% 0.05% $4,143,733
RENAISSANCE TECHNOLOGIES LLC 0.97% 626,000 +83% 0.01% $3,843,640
AWH Capital, L.P. 0.97% 625,000 0% 4% $3,837,500
CITADEL ADVISORS LLC 0.91% 588,409 +1.1% 0% $3,612,831
NORTHERN TRUST CORP 0.85% 552,410 +11% 0% $3,391,798
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 490,303 +17% 0% $3,010,460
GOLDMAN SACHS GROUP INC 0.71% 457,697 +54% 0% $2,810,260

Institutional Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 329,163 $2,184,780 +$220,351 $6.65 13
2025 Q3 54,269,227 $333,225,539 -$49,044,162 $6.14 158
2025 Q2 58,306,002 $536,933,982 +$27,282,133 $9.21 171
2025 Q1 54,269,937 $652,886,055 +$25,547,793 $12.03 178
2024 Q4 51,919,881 $573,092,988 +$6,644,610 $11.04 164
2024 Q3 50,293,278 $814,500,786 -$14,844,524 $16.20 164
2024 Q2 51,344,787 $557,095,592 +$21,881,644 $10.85 157
2024 Q1 49,346,121 $690,845,103 +$47,359,887 $14.00 159
2023 Q4 87,204 $918,259 +$324,292 $10.53 2
2023 Q3 41,317,381 $377,634,330 +$40,416,444 $9.14 133
2023 Q2 37,109,085 $269,852,686 +$15,236,469 $7.27 129
2023 Q1 34,125,262 $288,701,128 +$41,942,508 $8.46 123
2022 Q4 29,148,195 $218,903,303 +$13,702,654 $7.51 113
2022 Q3 25,504,594 $205,303,646 -$5,102,629 $8.05 118
2022 Q2 25,142,335 $291,646,664 +$15,738,529 $11.60 113
2022 Q1 22,860,984 $255,911,167 +$24,891,761 $11.22 112
2021 Q4 20,507,173 $132,682,619 +$17,208,153 $6.51 100
2021 Q3 17,416,349 $133,240,042 +$1,926,117 $7.62 108
2021 Q2 16,226,550 $205,279,316 +$96,492,407 $12.65 109
2021 Q1 8,605,085 $111,778,397 +$17,756,999 $12.99 92
2020 Q4 6,236,287 $20,952,709 +$2,381,741 $3.36 75
2020 Q3 4,536,644 $18,100,085 -$10,270,530 $3.91 74
2020 Q2 7,888,237 $41,809,893 -$20,253,653 $5.30 75
2020 Q1 11,511,395 $47,486,928 -$12,008,840 $4.15 89
2019 Q4 13,994,498 $170,303,743 +$67,322,657 $12.17 100
2019 Q3 5,522,729 $86,255,412 +$6,505,173 $15.62 89
2019 Q2 5,277,613 $77,160,624 +$17,327,460 $14.62 100
2019 Q1 3,758,952 $84,827,182 -$5,154,808 $22.57 87
2018 Q4 5,405,436 $64,323,153 -$25,491,523 $11.90 71
2018 Q3 6,635,744 $123,550,961 +$57,659,871 $18.62 66
2018 Q2 3,521,598 $98,567,769 +$802,052 $27.99 54
2018 Q1 4,445,338 $40,139,664 +$40,139,690 $9.03 39
2016 Q1 12,761 $286,000 $0 $22.41 1